WHO classifies three widely used medicines, including a common BP drug, as Group 1 carcinogens

WHO classifies three widely used medicines, including a common BP drug, as Group 1 carcinogensThe WHO's cancer research agency has classified Hydrochlorothiazide, Voriconazole and Tacrolimus as Group 1 carcinogens based on scientific evidence. The three medicines that were evaluated by WHO and the advisory issued include Hydrochlorothiazide (HCTZ), Voriconazole and Tacrolimus. Hydrochlorothiazide (HCTZ) is a widely prescribed thiazide diuretic used to manage essential hypertension and edema while Voriconazole is a broad-spectrum triazole antifungal drug prescribed for severe systemic fungal infections. HCTZ is phototoxic, when exposed to ultraviolet (UV) radiation from sunlight, the compound causes cellular oxidative stress in the skin”. WHO issues an advisory saying three common medications for BP are carcinogenicThe three medications are Hydrochlorothiazide (HCTZ), Voriconazole and Tacrolimus.